KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2018 | $52,000 | +62.5% | 5,650 | +197.4% | 0.00% | +200.0% |
Q3 2018 | $32,000 | +3.2% | 1,900 | +5.6% | 0.00% | 0.0% |
Q2 2018 | $31,000 | +3000.0% | 1,800 | +1100.0% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | +100.0% | 150 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | +100.0% | 150 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | -75.0% | 150 | -76.9% | 0.00% | – |
Q2 2016 | $4,000 | -42.9% | 650 | +30.0% | 0.00% | – |
Q4 2015 | $7,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |